Atika Capital Management LLC Axsome Therapeutics, Inc. Transaction History
Atika Capital Management LLC
- $841 Million
- Q2 2024
A detailed history of Atika Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Atika Capital Management LLC holds 49,000 shares of AXSM stock, worth $4.36 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
49,000
Previous 68,000
27.94%
Holding current value
$4.36 Million
Previous $5.43 Million
27.31%
% of portfolio
0.47%
Previous 0.63%
Shares
9 transactions
Others Institutions Holding AXSM
# of Institutions
289Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$413 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$294 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$210 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$165 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.82B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...